Nxera Pharma Co (TSE:4565) Tax Provision: 円2,420 Mil (TTM As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TSE:4565 Nxera Pharma Co Ltd TSE:4565
71 GF Score
Price 円1,190.00
GF Value 円892.71
Valuation Significantly Overvalued
! 9 Warning Signs
View Full Analysis

What is Nxera Pharma Co Tax Provision?

Nxera Pharma Co TSE:4565 -3.57% 71 Tax Provision is 円2,420 Mil as of Jun. 2026. GuruFocus rates TSE:4565 with a GF Score™ of 71/100 and a GF Value™ of 円892.71 (Significantly Overvalued). The stock has 9 warning signs investors should review.

Nxera Pharma Co's tax provision for the three months ended in Jun. 2026 was 円0 Mil. Its tax provision for the trailing twelve months (TTM) ended in Jun. 2026 was 円2,420 Mil.

Nxera Pharma Co Tax Provision Historical Data

* Premium members only.

The historical data trend for Nxera Pharma Co's Tax Provision can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Nxera Pharma Co Tax Provision Chart

Nxera Pharma Co Annual Data
Trend Mar16 Mar17 Mar18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Tax Provision
Get a 7-Day Free Trial Premium Member Only Premium Member Only 584.00 -696.00 3,487.00 -176.00 2,420.00

Nxera Pharma Co Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Tax Provision Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -811.00 1,444.00 391.00 1,396.00 0.00
TSE:4565
71GF Score
Nxera Pharma Co Ltd TSE:4565
Tax Provision is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Nxera Pharma Co Tax Provision Calculation

Tax to be paid.

Tax Provision for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was 円2,420 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Tax Provision →
What does a Tax Provision of 円2,420 Mil mean?
Nxera Pharma Co (TSE:4565) has a Tax Provision of 円2,420 Mil as of Jun. 2026. Provision for taxes is the amount of tax the company owes based on pre-tax income. View historical data on Nxera Pharma Co and its competitors.
Is Nxera Pharma Co's Tax Provision too high?
Nxera Pharma Co's current Tax Provision is 円2,420 Mil. Overall, Nxera Pharma Co has a GF Score™ of 71/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Nxera Pharma Co's Tax Provision compare to VRTX and REGN?
Nxera Pharma Co's Tax Provision of 円2,420 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Tax Provision for a Biotechnology company?
A good Tax Provision depends on the Biotechnology industry context. However, Tax Provision should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Tax Provision mean?
A high Tax Provision can signal that a stock is expensive relative to its fundamentals. Provision for taxes is the amount of tax the company owes based on pre-tax income. View historical data on Nxera Pharma Co and its competitors. Nxera Pharma Co's current Tax Provision is 円2,420 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Nxera Pharma Co stock overvalued right now?
Based on GuruFocus' analysis, Nxera Pharma Co (TSE:4565) is currently considered Significantly Overvalued. The stock's GF Value™ is 円892.71, compared to a current price of 円1,190.00 — trading 33.3% above its estimated fair value. The current Tax Provision is 円2,420 Mil. Nxera Pharma Co's overall GF Score™ is 71/100 with 9 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Tax Provision calculated?
Tax Provision is calculated from a company's financial statements. For Nxera Pharma Co (TSE:4565), the current Tax Provision is 円2,420 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Nxera Pharma Co (TSE:4565) Overvalued in 2026?

Based on GuruFocus' analysis, Nxera Pharma Co stock appears to be overvalued. The current stock price of 円1,190.00 is trading 33.3% above its estimated GF Value™ of 円892.71. GuruFocus considers Nxera Pharma Co to be Significantly Overvalued.

Key valuation signals for TSE:4565:

  • Tax Provision: 円2,420 Mil
  • GF Value™: 円892.71 vs. price of 円1,190.00 (33.3% above fair value)
  • GF Score™: 71/100 with 9 warning signs

No single metric tells the full story. See the TSE:4565 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Nxera Pharma Co Business Description

Other Exchanges SOLTF:USA
Address Midtown East, 9-7-2 Akasaka Minato-ku, Tokyo, JPN, 107-0052
Nxera Pharma Co Ltd is a science and technology-led biopharmaceutical company. Its activities are drug discovery, drug development and the commercialization of pharmaceutical products. The focus is to discover new medicines for unmet medical needs, including novel small molecules, peptides and therapeutic antibodies targeting G Protein Coupled Receptors (GPCRs).
71GF Score

Get the complete analysis for TSE:4565

Tax Provision is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円1,190.00
Price
円892.71
GF Value